Versant Venture Capital VI, L.P., 10% Owner at Oyster Point Pharma, Inc. (OYST), sold 1,096,557 shares at $14.63 ($16.3M) on 2021-10-18, disclosed to the SEC on 2021-10-20.
Open-market sale of $16.3M OYST by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.63 | 1,912 | $28K | 0.2% |
| 2 | $14.63 | 303,614 | $4.4M | 27.3% |
| 3 | $14.63 | 303,614 | $4.4M | 27.3% |
| 4 | $15.09 | 1,531 | $23K | 0.1% |
| 5 | $15.09 | 242,943 | $3.7M | 22.5% |
| 6 | $15.09 | 242,943 |
| $3.7M |
| 22.5% |
| Total | $14.83 avg | 1,096,557 | $16.3M | 100% |
| Filing → |
| GLUE | SELL | 2024-10-30 | $2.8M | — | Filing → |
| GLUE | SELL | 2024-09-24 | $14.8M | — | Filing → |
| TPST | SELL | 2024-08-12 | $1.4M | — | Filing → |